Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,628
datasets available to search
ShareScore release 0.9.0
Dataset results
1,628 results for “type safety”
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
ClinicalTrials.gov study NCT02229383. IPD Sharing: Not stated. Countries: 6. Publications: 2.
Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea
ClinicalTrials.gov study NCT02471404. IPD Sharing: Not stated. Countries: 5. Publications: 1.
An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00642278. IPD Sharing: Not stated. Countries: 13. Publications: 3.
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Empagliflozin in Chinese Female and Male Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01316341. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease
ClinicalTrials.gov study NCT01042977. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control
ClinicalTrials.gov study NCT03242252. IPD Sharing: NO. Countries: 16. Publications: 1.
Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00954447. IPD Sharing: Not stated. Countries: 19. Publications: 2.
A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events
ClinicalTrials.gov study NCT01959529. IPD Sharing: Not stated. Countries: 20. Publications: 15.
Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01294423. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine
ClinicalTrials.gov study NCT00975689. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness
ClinicalTrials.gov study NCT03163511. IPD Sharing: NO. Countries: 3. Publications: 3.
Safety, Tolerability, and Pharmacodynamics of IONIS-DGAT2Rx in Adult Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT03334214. IPD Sharing: NO. Countries: 4. Publications: 1.
Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01646320. IPD Sharing: Not stated. Countries: 8. Publications: 3.
A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics
ClinicalTrials.gov study NCT01119846. IPD Sharing: YES. Countries: 1. Publications: 1.
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy
ClinicalTrials.gov study NCT00688701. IPD Sharing: Not stated. Countries: 12. Publications: 2.
Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment
ClinicalTrials.gov study NCT00663260. IPD Sharing: Not stated. Countries: 13. Publications: 3.
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old
ClinicalTrials.gov study NCT03199053. IPD Sharing: YES. Countries: 23. Publications: 1.
Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01413204. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
ClinicalTrials.gov study NCT01498185. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy
ClinicalTrials.gov study NCT02384941. IPD Sharing: Not stated. Countries: 2. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.